Pharmaceutical Executive March 14, 2025
A panel discussion at the Global Life Science Partnering and Investor Conference discusses various strategies and trends in pharma investing.
A group of VCs convened at the BioCom La Jolla Global Investor Conference in late February for a panel discussion about the nuance between their strategies and those of traditional institutional VCs. Jim Krenn, partner and co-chair of emerging companies + venture capital group at Morrison Foerster, moderated the panel, which included the following panelists:
- Luba Greenwood, managing partner, Binney Street Capital Venture Fund, Dana-Farber Cancer Institute
- Jason Hafler, managing director, Sanofi Ventures
- Carole Nuechteriein, head, Roche Venture Fund
- Daniel O’Connell, MD, PhD, partner, Novo Ventures
- Asish Xavier, PhD, vice president of venture investments, Johnson & Johnson Innovation
Today's Sponsors
Today's Sponsor